Drug Shortage Report for LIPITOR
Report ID | 215527 |
Drug Identification Number | 02243097 |
Brand name | LIPITOR |
Common or Proper name | ATORVASTATIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 3x10 BL |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-01-11 |
Actual start date | 2024-01-10 |
Estimated end date | 2024-02-28 |
Actual end date | 2024-02-27 |
Shortage status | Resolved |
Updated date | 2024-03-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-03-06 | French | Compare |
v8 | 2024-03-06 | English | Compare |
v7 | 2024-02-15 | French | Compare |
v6 | 2024-02-15 | English | Compare |
v5 | 2024-01-16 | French | Compare |
v4 | 2024-01-16 | English | Compare |
v3 | 2024-01-12 | English | Compare |
v2 | 2024-01-10 | French | Compare |
v1 | 2024-01-10 | English | Compare |
Showing 1 to 9 of 9